The role of ASIC1a in neuroprotection elicited by quercetin in focal cerebral ischemia
Authors: Anil Kumar Mishra
Puja Panwar Hazari
Ranjana Patnaik
Anand Kumar Pandey
Journal: Brain Research (2011)
Discipline: NEUROSCIENCE & BEHAVIOR
Keywords: Retraction; Authors; Similarity; Images; Reproducibility
Affiliations: Division of Cyclotron & Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, Brig SK Mazumdar Road, Delhi 110054, India.

Abstract:  This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article is being retracted at the request of the Authors. The authors provided the following reasons: 1. The first author of the paper omitted the name of one of the contributors and did not disclose that he had been involved in similar studies at another Center. The results of these studies were previously published in another journal, resulting in a striking similarity between the images in this article and that of Mishra V et al., 2010 Neuropharmacology https://doi.org/10.1016/j.neuropharm.2010.08.015 2. The authors were not able to reproduce the results of the Western blotting data given in the paper. It should be noted that the Editor-in-Chief has serious concerns about the fact that some images in these studies were previously published in unrelated studies in another journal. 

Retracted: Yes

PubPeer comments:
 Authors could probably explain the similarity in images. The images are from two different publications with two different treatments.![file] , 
 The publication has an uncanny resemblence with the article published in  Neuropharmacology . Much of the text is similar along with this western blot image? ![image] , 
 Images recycled in another article. First one is treatment with Quercetin another one is treatment with Piroxicam.The image is appearing in  Paul S, Bhattacharya P, Pandey A, Patnaik R. Application of Mathematical Modelling as a Tool to Analyze the EEG Signals in Rat Model of Focal Cerebral Ischemia Journal of The Institution of Engineers (India): Series B. 2014;95(1):23-7. Different treatments same images?![file] , 
 More recycling of images in another article. Both images are of Quercetin treatment however first one is of pretreatment at different doses while the another one is of post treatment. The image is appearing in Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection Anand Kumar Pandey, Ranjana Patnaik, Dafin F.Muresanu, ArunaSharma, Hari Shanker Sharma, International Review of Neurobiology 102:107-146 (2012). Different treatments same images? ![file] , 
 Further recycling of images in another article. First one is treatment with Quercetin while second image is of Resveratrol treatment from article  Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection Pandey AK, Bhattacharya P, Shukla SC, Paul S, Patnaik R, Neural Regen Res 10:568-575 (2015). Different treatment but similar images? ![file] , 
 More recycling of images in another article. First one is treatment with Quercetin. Second image is of low dose Direct Current Electromagneto treatment from article  Ischemic Stroke and its Rehabilitation by low dose Direct Current Electromagneto Therapy Rupsha Mukhopadhyay, Sudip Paul, Pallab Bhattacharya, Ranjana Patnaik, International Journal of Advanced Information Science and Technology (IJAIST), Vol.4, No.3, March 2015. Different treatment same images? ![file] , 
 Retracted [25 November 2021] . ------------------------------------- This article is being retracted at the request of the Authors. The authors provided the following reasons: 1. The first author of the paper omitted the name of one of the contributors and did not disclose that he had been involved in similar studies at another Center. The results of these studies were previously published in another journal, resulting in a striking similarity between the images in this article and that of Mishra V et al., 2010 *Neuropharmacology* https: doi.org 10.1016 j.neuropharm.2010.08.015. 2. The authors were not able to reproduce the results of the Western blotting data given in the paper. It should be noted that the Editor-in-Chief has serious concerns about the fact that some images in these studies were previously published in unrelated studies in another journal. , 
 We have informed and requested the Editor in Chief in 2011 through email, to retract the paper by Pandey AK, Hazari PP, Patnaik R, Mishra AK. The role of ASIC1a in neuroprotection elicited by quercetin in focal cerebral ischemia. Brain Res 2011; published in journal Brain Research with the consent of all the co-authors due to the following reasons; 1. The First author of the paper did not mention the name of one of the contributors. 2. Second, We are not able to reproduce the results of Western blotting data given in the paper. We apologise to the Editor, Reviewers, Publisher and Management for all the inconvenience. Thanks for the consideration and I hope that this will not deter from submitting other manuscripts in the future. ( Through email in 2011) This was submitted in the year 2011 due to the internal concern raised on the Western blotting data which lead us to take a decision to retract the paper in 2011 which was communicated by email to Prof Irwin Levitan then editoru2013inu2013chief. Unanimously We decided to retract the paper without any corrigendum and forwarded our request to then Editor in chief to retract it and remove it from the site in 2011. We follow Professional Ethics seriously and didnu2019t hesitate to withdraw our paper in 2011 and the student was also terminated from the scholarship. It is to be noted that No Further publication was done from his thesis from our group. , 
 See also https: retractionwatch.com 2022 05 24 the-internet-may-be-a-challenging-venue-biomedical-engineering-group-up-to-four-retractions ,